• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格雷夫斯病患者眼外肌体积的决定因素。

Determinants of extraocular muscle volume in patients with graves' disease.

作者信息

El-Kaissi Samer, Wall Jack R

机构信息

Specialized Diabetes and Endocrine Centre, King Fahad Medical City, Dabab Street, P.O. Box 59046, Riyadh 11525, Saudi Arabia.

出版信息

J Thyroid Res. 2012;2012:368536. doi: 10.1155/2012/368536. Epub 2012 Feb 15.

DOI:10.1155/2012/368536
PMID:22496987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3306901/
Abstract

Background. To examine factors contributing to extraocular muscle (EOM) volume enlargement in patients with Graves' hyperthyroidism. Methods. EOM volumes were measured with orbital magnetic resonance imaging (MRI) in 39 patients with recently diagnosed Graves' disease, and compared to EOM volumes of 13 normal volunteers. Thyroid function tests, uptake on thyroid scintigraphy, anti-TSH-receptor antibody positivity and other parameters were then evaluated in patients with EOM enlargement. Results. 31/39 patients had one or more enlarged EOM, of whom only 2 patients had clinical EOM dysfunction. Compared to Graves' disease patients with normal EOM volumes, those with EOM enlargement had significantly higher mean serum TSH (0.020 ± 0.005 versus 0.007 ± 0.002 mIU/L; P value 0.012), free-T4 (52.9 ± 3.3 versus 41.2 ± 1.7 pmol/L; P value 0.003) and technetium uptake on thyroid scintigraphy (13.51 ± 1.7% versus 8.55 ± 1.6%; P value 0.045). There were no differences between the 2 groups in anti-TSH-receptor antibody positivity, the proportion of males, tobacco smokers, or those with active ophthalmopathy. Conclusions. Patients with recently diagnosed Graves' disease and EOM volume enlargement have higher serum TSH and more severe hyperthyroidism than patients with normal EOM volumes, with no difference in anti-TSH-receptor antibody positivity between the two groups.

摘要

背景。研究格雷夫斯甲状腺功能亢进症患者眼外肌(EOM)体积增大的相关因素。方法。对39例新诊断的格雷夫斯病患者进行眼眶磁共振成像(MRI)测量眼外肌体积,并与13名正常志愿者的眼外肌体积进行比较。然后对眼外肌增大的患者进行甲状腺功能检查、甲状腺闪烁显像摄取情况、抗促甲状腺激素受体抗体阳性情况及其他参数评估。结果。39例患者中有31例存在一条或多条眼外肌增大,其中仅有2例有临床眼外肌功能障碍。与眼外肌体积正常的格雷夫斯病患者相比,眼外肌增大的患者血清促甲状腺激素平均水平显著更高(0.020±0.005对0.007±0.002 mIU/L;P值0.012)、游离T4水平更高(52.9±3.3对41.2±1.7 pmol/L;P值0.003)以及甲状腺闪烁显像锝摄取率更高(13.51±1.7%对8.55±1.6%;P值0.045)。两组在抗促甲状腺激素受体抗体阳性率、男性比例、吸烟者比例或活动性眼病患者比例方面无差异。结论。新诊断的格雷夫斯病且眼外肌体积增大的患者比眼外肌体积正常的患者血清促甲状腺激素水平更高,甲亢更严重,两组抗促甲状腺激素受体抗体阳性率无差异。

相似文献

1
Determinants of extraocular muscle volume in patients with graves' disease.格雷夫斯病患者眼外肌体积的决定因素。
J Thyroid Res. 2012;2012:368536. doi: 10.1155/2012/368536. Epub 2012 Feb 15.
2
Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance.未经治疗且无临床眼病的格雷夫斯病患者,通过磁共振成像显示眼外肌(EOM)增大的频率较高。
J Clin Endocrinol Metab. 1995 Sep;80(9):2830-3. doi: 10.1210/jcem.80.9.7673432.
3
Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.甲状腺相关性眼病及相关疾病中针对眼眶靶细胞的抗体依赖性细胞介导的细胞毒性;血清细胞毒性抗体与眼肌功能障碍参数之间的密切关系。
J Endocrinol Invest. 1996 Jun;19(6):334-41. doi: 10.1007/BF03344966.
4
Hyperthyroidism in Patients with Graves' Ophthalmopathy, and Thyroidal, Skeletal and Eye Muscle Specific Type 2 Deiodinase Enzyme Activities.格雷夫斯眼病患者的甲状腺功能亢进症以及甲状腺、骨骼和眼肌特异性2型脱碘酶活性
Exp Clin Endocrinol Diabetes. 2017 Sep;125(8):514-521. doi: 10.1055/s-0043-113831. Epub 2017 Jul 27.
5
Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder?甲状腺相关眼病患者中抗横纹肌、结缔组织和核抗原抗体:Graves病应被视为一种胶原病吗?
J Endocrinol Invest. 1997 Nov;20(10):585-91. doi: 10.1007/BF03346914.
6
Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy.磁共振成像在甲状腺相关性眼病疾病活动度评估中的作用
Thyroid. 2002 Mar;12(3):223-7. doi: 10.1089/105072502753600179.
7
Sight-Threatening Graves' Ophthalmopathy during the Third Trimester of Pregnancy: A Case Report.妊娠晚期威胁视力的 Graves 眼病:病例报告。
Tohoku J Exp Med. 2020 Dec;252(4):321-327. doi: 10.1620/tjem.252.321.
8
Association between radioiodine therapy for Graves' hyperthyroidism and thyroid-associated ophthalmopathy.格雷夫斯氏甲亢放射性碘治疗与甲状腺相关性眼病之间的关联。
Int Ophthalmol. 2010 Aug;30(4):397-405. doi: 10.1007/s10792-010-9368-x. Epub 2010 Apr 20.
9
Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.停用抗甲状腺药物治疗一个月后进行促甲状腺素和促甲状腺素受体抗体检测,以此作为格雷夫斯病复发的预测指标。
Thyroid. 2005 Sep;15(9):1047-54. doi: 10.1089/thy.2005.15.1047.
10
Extraocular muscle sampled volume in Graves' orbitopathy using 3-T fast spin-echo MRI with iterative decomposition of water and fat sequences.使用3-T快速自旋回波MRI及水脂序列迭代分解技术测量格雷夫斯眼眶病的眼外肌采样体积。
Acta Radiol Open. 2018 Jun 25;7(6):2058460118780892. doi: 10.1177/2058460118780892. eCollection 2018 Jun.

引用本文的文献

1
Analysis of extraocular muscle volumes in idiopathic hypertrophic pachymeningitis patients.特发性肥厚性硬脑膜炎患者眼外肌体积分析
PLoS One. 2025 Apr 29;20(4):e0309638. doi: 10.1371/journal.pone.0309638. eCollection 2025.
2
Clinical and imaging evaluation of the response to intravenous steroids in patients with Graves' orbitopathy and analysis on who requires additional therapy.格雷夫斯眼病患者静脉注射类固醇反应的临床及影像学评估以及对需要额外治疗者的分析。
Clin Ophthalmol. 2016 Nov 17;10:2277-2289. doi: 10.2147/OPTH.S118555. eCollection 2016.
3
Graves' ophthalmopathy: the role of diffusion-weighted imaging in detecting involvement of extraocular muscles in early period of disease.格雷夫斯眼病:扩散加权成像在疾病早期检测眼外肌受累中的作用
Br J Radiol. 2015 Mar;88(1047):20140677. doi: 10.1259/bjr.20140677. Epub 2014 Dec 19.

本文引用的文献

1
Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?甲状腺相关性眼病的发病机制:针对肌浆网钙结合蛋白和ⅩⅢ型胶原蛋白的自身免疫是否起作用?
Clin Ophthalmol. 2010 May 14;4:417-25. doi: 10.2147/opth.s6534.
2
Association between radioiodine therapy for Graves' hyperthyroidism and thyroid-associated ophthalmopathy.格雷夫斯氏甲亢放射性碘治疗与甲状腺相关性眼病之间的关联。
Int Ophthalmol. 2010 Aug;30(4):397-405. doi: 10.1007/s10792-010-9368-x. Epub 2010 Apr 20.
3
Mitochondrial abnormalities in eye muscle fiber from three cases of thyroid-associated ophthalmopathy.
Thyroid. 2006 Nov;16(11):1181-3. doi: 10.1089/thy.2006.16.1181.
4
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers.格雷夫斯眼眶病患者的临床评估:欧洲格雷夫斯眼眶病研究小组给全科医生、专科医生和临床研究人员的建议
Eur J Endocrinol. 2006 Sep;155(3):387-9. doi: 10.1530/eje.1.02230.
5
Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease.促甲状腺素受体自身抗体是格雷夫斯眼病的独立危险因素,有助于预测该病的严重程度和预后。
J Clin Endocrinol Metab. 2006 Sep;91(9):3464-70. doi: 10.1210/jc.2005-2813. Epub 2006 Jul 11.
6
TSH receptor protein is selectively expressed in normal human extraocular muscle.促甲状腺激素受体蛋白在正常人眼外肌中选择性表达。
Muscle Nerve. 2005 Jul;32(1):95-8. doi: 10.1002/mus.20315.
7
Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management.
Intern Med J. 2004 Aug;34(8):482-91. doi: 10.1111/j.1445-5994.2004.00662.x.
8
Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease.临床综述157:格雷夫斯眼病的病理生理学:疾病循环
J Clin Endocrinol Metab. 2003 May;88(5):1939-46. doi: 10.1210/jc.2002-030010.
9
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience.格雷夫斯眼眶病患者特征及治疗策略的多中心研究:欧洲格雷夫斯眼眶病研究组的首次经验
Eur J Endocrinol. 2003 May;148(5):491-5. doi: 10.1530/eje.0.1480491.
10
Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease.检验医学实践指南:甲状腺疾病诊断与监测的实验室支持
Clin Endocrinol (Oxf). 2003 Feb;58(2):138-40. doi: 10.1046/j.1365-2265.2003.01681.x.